AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

aTyr Pharma Inc. (ATYR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.63

0.00 (0.00%)

At close: Jan 30, 2025, 11:48 AM

undefined% (undefined)

Bid	3.63
Market Cap	304.71M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.94
PE Ratio (ttm)	-3.86
Forward PE	n/a
Analyst	Buy

Ask	3.64
Volume	295,575
Avg. Volume (20D)	822,806
Open	3.66
Previous Close	3.63
Day's Range	3.63 - 3.83
52-Week Range	1.42 - 4.22
Beta	undefined

About ATYR

A detailed description of the company is not yet available....

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date n/a

Employees 56

Stock Exchange NASDAQ

Ticker Symbol ATYR

Analyst Forecast

According to 5 analyst ratings, the average rating for ATYR stock is "Buy." The 12-month stock price forecast is $16, which is an increase of 340.77% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

3 months ago

+7.47%

aTyr Pharma shares are trading higher after Wells ... Unlock content with Pro Subscription

News

3 months ago · seekingalpha.com

aTyr Pharma: The Bull Has Finally Come Out

aTyr Pharma has a pivotal year ahead with key readouts for Efzofitimod in pulmonary sarcoidosis and SSC-ILD, potentially opening a huge market. Efzofitimod aims to modulate inflammation without immune...